近日,中國首個新冠疫苗專利獲批。該疫苗在國內和國際分別率先進入I期、Ⅱ期臨床試驗,驗證了疫苗的安全性和免疫原性,Ⅲ期國際臨床試驗正在有序推進。據《柳葉刀》報道,當前全球大約有250種候選新冠病毒疫苗在研發中,其中至少有17種正在臨床試驗階段。https://bit.ly/3g3wUej pic.twitter.com/G4rBpsje3Y
8:30 PM - 16 Aug 2020
1 reply
4 retweets
10 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.